Zainab Abbas
Dermatology · Worcester, MANPI 1609028000
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,179 of the $1,897 with a category attached, or 62.1%. Pfizer accounts for 93.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $1,764 and has fallen 97.5% since, to $45 in 2025.
Across 11 payments — averaging $172.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2K
- AbbVie$62
- UCB, Inc.$23
- E.r. Squibb & Sons, L.L.C.$18
- Lilly USA, LLC$15
Across 86 payments — averaging $3842.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$240K
- AbbVie$91K
What the payments were for
- Travel & lodging$1,17962%
- Food & beverage$70337%
- Education$151%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 5 | $1,779 |
| AbbVie | 3 | $62 |
| UCB, Inc. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
How this compares
$1,897 in reported general payments places this provider in the 55th percentile of 552 dermatology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 123 | $2,435 |
| Tacrolimus | 13 | $947 |
| Metronidazole | 19 | $837 |
| Fluorouracil | 13 | $773 |
| Mometasone Furoate | 26 | $613 |
| Mupirocin | 26 | $236 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Worcester
- John HarrisWorcester$15M
- Seth KatesWorcester$64K
- Mehdi Rashighi FiroozabadiWorcester$19K
- Ethan LernerCharlestown$1.7M
- Michael KaminerChestnut Hill$1.1M
- Jeffrey SobellChestnut Hill$986K
- Erik DominguesFall River$736K
- Alexandra KimballBoston$680K
- Arash MostaghimiBoston$591K
- David GreensteinBeverly$540K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.